Discovery of Novel PTP1B Inhibitors by High-throughput Virtual Screening
The identified molecule could potentially manage T2DM effectively by inhibiting PTP1B, providing a promising avenue for therapeutic strategies.
Authors
- Anjna Rani (ORCID: https://orcid.org/0000-0002-7575-7580)
- Jahanvi Sanchitra
- Rajesh Kumar Singh (ORCID: https://orcid.org/0000-0002-0417-0627)
- Avijit Mazumder (ORCID: https://orcid.org/0000-0002-3053-8106)
- Shalini Sharma (ORCID: https://orcid.org/0000-0001-9864-6720)
- Navneet Khurana (ORCID: https://orcid.org/0000-0001-9899-4856)
- Rupa Mazumder (ORCID: https://orcid.org/0000-0002-1888-548X)
- Shikha Srivastava (ORCID: https://orcid.org/0000-0002-1970-8370)
- Sk Ashif Jan
- Hema Chaudhary (ORCID: https://orcid.org/0000-0002-0207-8325)
- Abhijit Debnath (ORCID: https://orcid.org/0000-0003-1056-1197)
- Rashmi Mishra (ORCID: https://orcid.org/0000-0002-7558-1714)
Institutions
- University of Delhi (IN)
- Lovely Professional University (IN)
- Jaypee Institute of Information Technology (IN)
- KR Mangalam University (IN)
- National Institute of Pharmaceutical Education and Research (IN)
- Institute of Medical Sciences (IN)
- Banaras Hindu University (IN)
Publication Details
- Journal
- Current Computer - Aided Drug Design
- Published
- 2024-10-16
- DOI
- https://doi.org/10.2174/0115734099278007241004105500
- Citations
- 7
- Primary Topic
- Protein Tyrosine Phosphatases
- Type
- article
- Field-Weighted Citation Impact
- 1.64